Prescription drug coupons can offer short-term financial relief. But everything is not as clear or beneficial as they make it out to be. Using these coupons can be complicated for patients with health insurance, as hidden costs affect the long-term financial picture.
In this sense, insured patients have reduced the use of aforementioned coupons, especially anti-obesity analgesics, a figure demonstrated in a study recently published in Journal of the American Scientific Association (JAMA). This suggests a change in the relationship between insurers and manufacturers.
It is worth noting that the manufacturers offer the same number of products, “but even so, we see a lot of affordability problems among this population with private health insurance,” says So-Yeon Kang, essential author of the study and assistant professor of health management and policy at Georgetown University, according to statements collected by KFF Health News.
Coupons can even help patients reduce out-of-pocket expenses, but they don’t necessarily count toward annual deductibles. This creates confusion about when and how to use them effectively.
Where is the problem?
President Donald Trump promised cheaper medicines, and this is partly true, because some prices actually went down, but others skyrocketed.
Let’s see, drug manufacturers distribute discount coupons to consumers online or in person at the pharmacy, but for their brands, which, of course, are more expensive, and these sponsored coupons do not allow access to generic products, cheaper even than discounted drugs. There is a difference here compared to, for example, the discount card services of companies like GoodRx, which negotiate lower volume prices for prescription drugs and then pass those savings on to the consumer, explains an investigation by KFF.
Consumers pay less out of pocket, often for brand-name drugs, but more than for generic versions.
On the other hand, for those without health coverage, coupons can be a beneficial tool. The new TrumpRx initiative provides access to coupons, but its effectiveness is limited to a specific number of medications: about 85, among thousands approved by the Food and Drug Administration (FDA).
Government restrictions
There are also federal restrictions that prevent Medicare and Medicaid beneficiaries from using manufacturer coupons, further complicating the financial situation for this vulnerable population.
Additionally, some states impose restrictions on coupon use when generic options are available, underscoring the complexity in the interaction between health policies, manufacturers, and insurers.
You may also be interested in:
· DNA tests sent by mail, a new method in the detection of colorectal cancer
· FDA Announces First Approval of Fruit-Flavored E-Cigarettes for Adults
· Interested anxiety?: FDA accelerates review of three psychedelic drugs
